# Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension

> **NCT01523548** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Illinois at Chicago**

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** Carbon Monoxide

## Key facts

- **NCT ID:** NCT01523548
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding and subject acuity
- **Last updated:** 2017-06-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523548, "Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01523548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*